Fifth, enhancing microglial activation via LPS exacerbated tau pathology in both the 3xTg mouse model of AD and rTg4510 mouse models of tauopathy (Kitazawa et al., 2005; Lee et al., 2010b). This evidence concerns the gene MAPT and Alzheimer disease.